---
title: "DeSci Office Hlurs | Twitter Space Recording | AlphaGrowth"
description: "Twitter Space Recording from 2025-09-01 with Molecule, Methylene Blue, Karlin Compton"
url: "https://alphagrowth.io/spaces/desci-office-hlurs"
---

# DeSci Office Hlurs

Recorded: Sep 1, 2025 Duration: 0:54:58

## Space Recording

[Open Original Space](https://x.com/i/spaces/1BdxYZBAOAEKX)

0:00 54:58

### Full Transcription

Thank you. yeah

yo yo gm gm gm gm how are you doing good keeho how are you buddy i'm good man all right let's get to bed uh let's get into it

dsai office h-lurs h-lurs yeah sorry for the typo guys yeah we've been in a bit of uh hurry

but yeah welcome to dsai office hours i'm keeho uh your dsai office our host along with carlin

your DCI office, our host, along with Carlin.

I'm reporting from south of India.

It's half past eight, as usual.

The weather is a little chilly here.

Yeah, enjoying my last days of summer.

It's going to get colder from now on.

How are you doing, Carlin?

I'm doing well.

I'm Carlin.

I'm Kehoe's beautiful co-host.

And I'm reportinglin. I'm Kehoe's beautiful co-host and I'm reporting from Chicago. It's Labor Day for us here so I'm taking the time off lab. It's a beautiful day. Exc? Yeah, what is new? What's new with you, Tio?

On the headlines, I see a new token launched on Molecule. It's called Dollar Fiddle.

And yeah, I've been looking at the charts recently. Yeah, I think it's a very good project,

in my opinion. And this is one of the first projects I got to work with when I started.

Oh, really?

Yeah.

Maybe share a little bit more with us about feedback and the project behind it.

Yeah.

So $fiddle is the token of a project called Transfidelity.

And I came up with this name.

So this project is basically targeting something called

translation this is a very important process in our body i would say at a cellular level

what happens is we need proteins right to build up our muscles to build different things we need

proteins so proteins are basically getting translated out of your you know RNA which is coming out of DNA

so this is how it goes you have a genetic material which codes for protein and then

interesting molecular machineries come in like these are like simple robots that I would call

it as printers protein printers so yeah exactly these 3d printers these protein printers

print proteins and this printer has a let's say a fault rate uh around like thousand proteins it

might make a faulty protein so because of this reason what you are doing is you are creating a

lot of uh you know waste proteins and this is going to improve the stress for the cell to remove these waste out of the system.

And that's where the project TransFidelity comes in.

The project is trying to fix that error rate and make the translation process more efficient so that we don't produce a lot of waste.

And this could be easily mitigated so yeah that's project

trans fidelity and the token name is dollar fiddle and yeah to be specific the the researchers in

this project are targeting alzheimer's disease one of the key neurodegenerative disease because

if you look at the pathology, this is Alzheimer's

is happening due to overproduction of a certain protein in our brain cells.

Right.

We need to like the aggregates and stuff.

Exactly.

These aggregates kind of hurt the cell.

So this is why like, yeah, junk proteins, right?

So we are trying to fix that printer uh the protein printer so that it

doesn't make enough make those errors and a lot of junk proteins so we are like kind of targeting the

the uh how would i say the core of the problem we are not trying to fix symptoms here this is

the d core like you know the core you cannot go further beyond this like this is already attacking

at a molecular scale if you want to go further you need to do more atomic uh sort of attack so

i think we are at the best uh possible site we are improving this uh this is going to improve

a lot of different things uh primarily aging uh you know the longevity could be like really interesting when you fix

this sort of error rates let's see like you know at a cellular level reducing burden to the cell can

improve your longevity to a greater extent so yeah i'm super excited for this project the project is

run by researchers from University of Zurich from Switzerland I got into this project last year and

run by researchers from university of zurich

we've been like you know doing the deal flow and trying to get this token out and successfully

last weekend we launched dollar fiddle so yeah if you guys are interested if you guys are somehow touched by you know Alzheimer's disease from your you know personal story or

like your kitten can has this disease it'll be interesting to go have a look

at this project yeah I'm really curious about it could you maybe share a little

bit more do you if know, about like the,

what specific method are they, are they using or like, what's the, what's the move from where

they're at right now with the stuff that was raised with the Fidel token?

You mean the, the, the scientific mechanism became the, yeah. What are they, what are

they testing? How do they testing how do they

how are they doing it yeah uh so they have a a library of uh compounds molecules um you could

see like bunch of compounds being already tested in uh pump science as well but we don't really

look at the we got a couple on the we got a couple on the call today too we might hear from them

later exactly so we are not directly

looking at the molecular mechanisms in pump we are looking at organismic level but now this project

will be looking more closer to the molecular level yeah yeah and and basically we are screening these

compounds uh and seeing whether this uh improves this you know uh error reduces the error error rate within this protein printers

directly targeting that so you basically take a protein printer which is a ribosomal RNA which is

gonna do the translation and you're gonna try it with different bunch of compounds which goes and

binds to this and try to make the printer more efficient um that's the screening and i think so good news is they already screened

and have a bunch of compounds already now they want to test it on mice um cool i want to see

that like whether this has a positive uh impact on elevating these you know like protein aggregates

in alz Alzheimer's disease.

So they'll be trying for Alzheimer's as specific case in the beginning.

But as you understood, like this protein printer is very, you know, sort of a functional unit that cell has.

So this is a key thing that we need to like target.

And this might have like a greater upscale effects upstream effects so yeah let's let's wait and see uh how these things go i'm interested in those you know

like lucky compounds you know if you could get hand on those compounds probably we could already

try taking those to improve the uh fidelity but yeah these are like yeah as i say intellectual property protected assets so

oh yeah it's like the if you know of uh beta rna it's kind of like the the next downstream step of

what beta rna is doing where they're trying to do the you know the cell gene therapy to get rid of

um miss miss uh miscoding like coding errors errors in the DNA sequence. And then even further,

like you've got the right sequence. Now let's make sure that the end product is what it said

in the blueprints. So that's pretty cool. Exactly. So I think we are kind of fine-tuning

all those molecular mechanisms we have. The central dogma is de-sized, right?

Yeah, exactly. If you are a biologist, you know what central dogma is d size right yeah exactly you know if you are a biologist

you know what central dogma is central dogma dictates like how uh an organism is made like

what's the basis of all the living organisms so you start with dna which is like the four uh base

uh molecules and you can compare this to zeros and ones like with computers right so zeros and

more complex binary exactly so this is like tertiary like you have four bases instead of zeros

and ones and if you shuffle this uh four bases you might uh end up being an ant or you might end up

being an elephant or you might end up being a microorganism or a human, right?

You just need to shuffle this thing.

And this part is DNA.

And if you want to build an organism out of it, you need to have proteins like to build muscles,

build hair, eyes, and all of that.

So that entire information is written in DNA.

So you need to translate this to make a protein. So is the central dogma DNA to RNA to protein and these projects

that Carlin mentioned like Vita RNA and trans fidelity these projects are

targeting this central dogma of biology so that you know we are attacking aging from like uh i would say swiss knife precision

if if this works i don't know like this is gonna be a crazy time to live i i would i would often

for these therapies man this these are like uh interesting therapies you don't have to like

really do a lot of surgery like just taking compounds this is gonna make your system more efficient

that's it yeah it's nuts I am I'm really excited about where the like you know these building

blocks of our of our you know the nature of who we are are being made more efficient and more, like you said, more have higher fidelity.

Yeah. And over the last week, I also saw like a bunch of Pump Science tokens launched.

Oh, yeah. On Pump Science Alana ecosystem. So I think Lsd got launched psilocybin got launched

psilocybin boobs got launched boobs was crazy huge uh what else did we see morphine i'm excited

about that one i think that's interesting a couple of um i think like doxycycline or something like

that also got launched yeah yeah i've been following this and

i think raptor is like uh again like killing it uh oh yeah oh yeah i'm following the charts man i

know i know my uh yeah compounds oh yeah that reminds me um ethan from raptor he's been he's

been doing this thing where instead of buy back and burn for the for the raptor token he buys back in stacks um so instead of you know removing the the shares of the token from trading

entirely he's buying them and to show you know positive uh price uh you know positive beliefs

in the project and then you know keeping those things so that they could potentially be used for the future uh what do you think about that keeho i really think this builds a lot of confidence

on the project like you know devs uh the project uh team holding the tokens this creates that uh

trust for the token holders and uh ethan being like a rock star, right? Like he has built Qutopia and he is doing it all single-handedly.

And he's a rock star scientist, entrepreneur, design builder, whatever you can label him, right?

So I think this is a lot of reputation involved in this.

I would love to see more such, you know, these token devs coming in, like pump science devs coming in and building that trust within the ecosystem.

That's quite important.

And yeah, yeah, I'll end it there.

Yeah, absolutely.

Speaking of pump science devs, I think we got uh another speaker on if maybe we want to

hear from methylene blue

yeah let's hear from methylene blue yeah hey dev what up

probably he's trying to set up his mic uh yeah probably

uh yeah probably

this is one i'm excited about as well um methylene blue everybody in the longevity space has been

talking about it i'm scared to take it though i don't want to i don't want to turn blue

i have taken this i have taken this i think it was during one of my one of the last pop-up cities

it was during one of my uh one of the last pop-up series uh my my do they have like a

no no no he you know he he had like bunch of oh he came with it yeah he brings this blue

yeah yeah he got the goods he he bought this blue water and then that's when i first uh you know like

came across methylene blue and benji like benji has been talking about Methylen Blue for a long time

yeah so I tried it it's it's more like you know I would say somewhere between somewhere less than

coffee because I don't like the dose that I took is somewhere very less but yeah it gives something

closer to coffee but I would see I would say like there could be like

bunch of other long you know like downstream efforts as well like other

than just my mental clarity the no tropic effect you could also expect some

more other effects out of methylene blue but yeah to hear it from the dev uh yeah

that is hey sir are you there

i don't see him i don't see him reacting to us uh yeah probably he can come and join us as we go forward yeah whenever he's ready yeah

speaking of nootropics that's um that makes me think of nootropic dow and you know pnl

pinealayan and um they've got some new stuff brewing as well which i thought was really

interesting let me look it up so i can get the details right. The new TropicDAO devs are some of my favorite people in the Pump Science Telegram because they really don't care for futters.

And I like that attitude.

Yeah, I was in touch with one of their team members.

He's running the shop.

Basically, he has all those like supplements that you want in

the world like he has all those stacks so we were building uh like bunch of supplement stacks for

microband now and we reached out to nootropics to help us source these things uh yeah definitely

they're they're super deep into this um also have you heard about this uh

nootropics depot i don't know whether they are like somehow linked or this but

this is a very good vendor to purchase nootropics or like any sort of supplements in my opinion

because i have seen like bunch of videos they go through this they do this all analytical tests to

prove okay their supplement has whatever they are claiming to be there in the back label right

and this builds a lot of trust and i think pump science is moving pump science and molecule along

is moving along this way imagine like you know molecules or compounds uh coming out of pump science tested

until mice and then now this can graduate to go for a human trial yeah this human trial would

yield like enough information regarding its toxicity effects and all of that and if you

would record all this information uh on chain right like putting this as

poi or ipnfts or like at least having those uh data trail kind of documented on chain this will build

a lot of trust for those buyers who purchase these uh you know supplements and consume them right

because you then have like a whole history of where this compound is coming from

how this being tested what are these effects and all of that yeah and I think that's the future

man like we cannot be kept in dark for a while right like we need to you know really bring these

new tools in rails to be aware of what we are consuming every day. Yeah, and all the information produced is just

more data. And in this age, data is like, that's what's worth the money, basically, of, you know,

using this stuff so that people don't waste their time and effort on other compounds or,

you know, on things that have previously been shown to not work. What I think has been really cool to see is even in the compounds that we've not seen

maybe be the most successful in, in like increasing lifespan, we're seeing like new,

new partnerships and new combinations sort of be born out of that. So it's, I think, a really interesting, I mean, I'm excited for the future of punk science

because who knows, maybe a combination that even the most astute scientists had never

thought of, but some, you know, outsider with no any preconceived notions is going to come

in and change the game.

And I think that's what's beautiful about decentralized science.

It is. It is, it is.

All right.

Methyl and blue, are you ready?

Hey, sorry.

I'm in the lab right now in the work.

So only I want to say that Methyl and blue

is being trained for Alzheimer too.

So maybe we can make

some investigation or combination with another drug.

Cool.

Cool.

So what are the effects of Methyl in Blue, quickly for our listeners here? here and he reacts in the in the electron chains on on the mitochondria and

it's a it's a mental drug all right so i will share some papers in fact if you're showing to

to the telegram group and there we we always and we always keeping and share

these these papers right sorry I'm in the world right now so I must to be

quickly no worries man no worries thank. Yeah, we'll share the link

to the Pump Science Telegram with this so that people can join and check out the

Methylene Blue section. You definitely, Methylene Blue's dev is pretty active in the group and

and is constantly giving us some updates on, you know,

it's constantly giving us some updates on, you know, the science and how it works.

the science and how it works.

From what I'm hearing,

it sounds like something mitochondrial related,

which is always, always great.

I feel like we could never have too much energy

and, you know, pumping up that powerhouse.

Cool, thank you cool so uh next up i just want to briefly touch on uh the the hero of the dcivers obre ai oh yeah it's already a week since obre launched yeah we were just talking about it this time last week, right? Exactly. Yeah.

And I've been looking at the chance. What was it, then? 800 POIs at the time?

Yes. At the time, 800. Now it's 1,500 POIs. Almost double. Wow.

It is. Can you briefly explain what are these POIs for our listeners here who might be new to this podcast?

Yeah, yeah. So if you're if you're not aware, a POI is a proof of invention. And for those who

might not know, in, you know, when you create an invention, or when you come up with an idea,

it's often hard to defend when that idea actually came to be. And what POI is, is essentially an on-chain

tracker or, you know, lock-in of that, like, point in time when the idea that you came up with

became an official idea that's now, you know, able to further be patented and stuff like that.

And so what the POI is, is it's all these different hypotheses coming together that, you know, will lead to potentially, if they're, you know,

something testable, they can then be become IP NFTs, where they're now a, you know, defendable

idea that can be sort of, you know, developed further through some different governance mechanisms.

And then eventually that IP NFT can become an IPT, which is an IP token.

And then that can then be further, like, you know, officially traded for future, for future, you know, development of the project and for the hopefully downstream commercialization of

any anything that would come out of that initial idea. And so what Abreyad has done so far is it

has created a bunch of these hypotheses and then hopefully the ones that are tested and vetted can

then go down to become the IP nfts and if people show support

to the ip nfts then those can then be you know launched as their own token sort of communities

as well um does that kind of explain it keigo anything i missed no it does explain it very well

yeah thanks for that yeah ip for those that aren't aware, is intellectual property.

And it's just a lawyer or legal way of saying ideas.

Yeah.

And Aubrey is trading at current price $15.90 and with a market cap of $ 31.8 million dollars wow 31.8 million dollars

oh my goodness i wish yes i mean this is i'm glad i got in yeah you need to wait for the next agent

then yep yes what's the next agent coming up do you know uh sorry i cannot i cannot like uh talk

about this openly but i know like uh there are like bunch of agents coming up soon and uh you

can't share a little alpha with us yeah yeah um biome ai is one of those agents. And then we have DigGPT from DigDog.

Oh, yeah.

Oh, yeah.

Oh, yeah.

So these couple of agents are definitely in the line.

Let's wait and see when these launches are going to go live.

But I'm super excited for both of these agents.

uh both of these agents i have got my hand to my to my uh crypto wallet ready to ready to

pounce on that uh bio may i yeah i hope you have enough uh xp yes i i pumped quite a bit into abri

i but i think i've i've been accruing even more now that i can actually like stake my bio awesome awesome yeah

that's good i'm full dj you did it man awesome awesome yeah welcome welcome back yeah i would

say like last year this time i've never like you know got into got so deep into the web 3 world uh and then you remember the dsai

uh winter or like dsai tsunami that i would call it this was last year i guess yeah last year at

the end of the year exactly yeah close to christmas right yep yeah and this is when um

our founders from bio protocol and molecule along with bunch of other

folks from quantum by and all of that like they met at uh defcon bangkok uh at the dsci convention

with vitalik and cj and uh this was the turning moment for the entire dsai and after that event it went crazy and crazy and

and that's when exactly pump science came out right like yep it created that decent funnel

for people to come into dsai and interact with it and uh solana has definitely been that space for

you know like with the right kind of community to embrace the side and then from there

on uh it's been super chaotic and i i remember like carlin and i uh were first time moderating a

uh a telegram chat full of djans and uh did not know what we signed up for

yeah i still have nightmares looking at those chats but yeah it was a chaotic but like very wonderful

experience to to get into get onboarded into this world and from then on like it's it's been uh you

know uh yeah uphill it's really been cool because there's some people from those very early days when pump science did their

riff and euro launch that are still hanging out in the space and i think that that's that's pretty

cool to see the like traction and long longevity that we've seen so far for these sides it's hard

for people to stay interested for a year you know for for a month on things let alone a year you know so pretty cool to see and it's also

it's great also because it showed that you know the d site ecosystem works best when it builds

off of each other like the hike from you know the bio protocol and all that stuff leading to

more of the you know pumping of the of the you know cy cymine coins all that stuff rising tide listening

yes i think uh there's definitely i think the collaboration is the key because we all have

enough uh you know like things to collaborate with and enough market to capture so this is just the beginning i think instead of competing each other

dsai should really look to uh you know look forward to collaborate with each other and and

push the space together forward and i think that's that's the way to go forward man like uh

especially like with the sort of uh the crypto rails that we are building the the new science economy uh we need

to focus on building those collaborative rails exchange between communities uh all those dows

coming closer projects kind of you know leaning in on each other uh we are also like currently in

in talks with pump science to integrate with biome AI to kind of stream in,

you know,

like the hypothesis that we generate could be then tested with the pump

science or like pump science,

like whatever molecules that are graduating out of pump science could also be

then tested using Biome AI for a,

for a human cohort study sort of.

I like that. Yeah. that yeah yeah would you would you

guys want to be like a tier of funding like maybe people reach a certain threshold and it triggers

the the biome ai testing yes something like that yeah yeah post mice trials you will be uh able to

get into the uh yeah biome ai trials and And we do something called N is equal to 10 hypothesis, kind of inspired from Brian Johnson and his N is equal to one movement that really changed the longevity space because he tried a bunch of different supplements, therapies and stacks on him.

And then he built this, you know, n is equal to one longevity knowledge around him.

And he already created a brand around that, right?

So we're kind of picking this up

and scaling it to a next level, n is equal to 10.

Then you will be able to kind of build

a micro community study, right?

Like, let's say we are around 12 here.

So if all 12 of us wants to track something uh very interesting probably

like uh like our uh trading behavior or um you know like whether our midnight coffees affects our

uh morning clarity and stuff like that simple things right so then then it's possible for those 10 people uh to come uh you know closer for an aligned uh trial that

they want to test because um you you see a lot of bs in the in the in the space that we are uh

especially with the health influencers going around saying yeah you need to do call and cleansing

yeah there's no science drink this juice yeah exactly you need to do this fasting you need to

do this you need to fast for 72 hours i don't know exactly it's it's it's it's not gonna work

for everyone that's that's the fact right like it's not gonna work for everyone the same way

because our genetics are different our microbiome is different our environment our food that we eat is different so also the work that we

do is very different so it's not going to work for everyone so that's why this ns equal to 10

trials will be very an integral key for testing these things okay if someone says okay fasting

for 72 hours is good if if people wants to test it those 10 people who are ready

to test that 72 hour fasting can come closer and then they can map you know whether this trial this

hypothesis does work or not and out of that comes another hypothesis which is like a tested hypothesis

sort of it says okay probably this works this way, but not to an extent.

And you can take this idea or the hypothesis, like an assumption,

and put it on prediction market, as we discussed, right?

Like polymarket prediction.

You can put this on a prediction market and let a bigger cohort to test it.

Let's say 100 people who have the same question can come and bet on this, right?

And for this, you can use Aubrey AI. You can can use bunch of these ai tools to make the best bet so there is a whole economy scientific

economy brewing out of this system you know like where citizens will become scientists because

the thing that they are lacking is basically tools to do science if you have the analytical ability to

investigate onto something uh you just need bunch of tools to you know like speed up the process

and usually science kind of the scientific community kind of gate kept these tools yeah

yeah you need to go through a long long years of education you need to answer all those questions

and all of that who needs it yeah no you don't need that you just need like a couple of air

agents who are able enough for running those uh you know simulations for you yeah and then you can

also be a scientist you know exactly and i think this is gonna this well i don't know i would call it as cambrian explosion because uh

you know the cambrian explosion in biological terms is something uh when you know there was a

period called uh cambrian era uh out of different eras that we have like the living organism has

survived through like jurassic era we had cambrian era but

this whole cambrian era got wiped out due to catastrophic climatic conditions and volcanic

eruptions and all of that and then 0.5 percent of this uh you know organisms living organisms

survived the uh catastrophe and then they kind of exploded into like you know creating this new world that we

really see right they started multiplying they started cross-pollinating they're evolving into

something else and that we call cambrian explosion of biodiversity so we might expect something like

that happening when you give these tools to everyone in the world and make it more affordable and accessible for

the whole of humanity probably we might evolve into something like a hive mind right if everyone

starts using these tools imagine you are talking so instead of one obre working on solving the

longevity issue imagine all all of us using obre to solve those longevity issues or imagine we

have a bunch of different scientists onboarded as these agents we can use

them to solve bigger issues from our perspective or like our kind of

capabilities right so just gonna speed up the innovation rate speed up like you

know cost efficiency testing pace and all of that i think we are challenging

uh the the scientific uh you know the dogma being set up by early 80s and 90s you know like this

academia kind of gatekeeping all the knowledge and then on top of that you have the the consumer

wing being the big pharma spinning out of academic knowledge and creating these drugs

and not really trying to solve any cure any problems rather than creating more diseases and

just trying to solve the symptoms right like treat the symptoms not to the cure

probably if people like us would try to solve this we would be targeting

People like us would try to solve this.

We would be targeting to create some cure for these diseases.

What do you think of this new era that we are entering into?

Absolutely.

I think the way having you talk about the Cambrian explosion really just clicked for me because that was the original bio act.

You know what I'm saying?

Like that was rapid evolution over a very you know

relatively short amount of time and i think that we as we as um you know human beings are hopefully

reaching an age where we're able to grab these tools that you know a lot of pioneers are creating

and you know accelerate for ourselves i think of you know, accelerate for ourselves. I think of, you know, your N of

10 and your different things, like what if instead of N of 10 of random curious people,

it's now your N of 10 of your friend group or something like that too, because then we not

only get information on, you know, how this, how these different processes affect, you know, 10,

10 distinct people, but also people who, you know, spend time together and hold each other accountable and in different ways to like, you

know, different, different habits and activities to better understand, you know, some of the,

some of the things involved in everyday life that aren't necessarily like therapeutic related,

but can be, can feel like therapy for us sometimes I

think that the possibilities for what can be you know discovered through the

through these methods it's gonna be you know yeah exponential it's by lack as

by rack we are moving towards the biasing the LARITY yeah yeah we're all

we're all one but we're also all different yeah so i i this statement like was

really resonating with me for the last week because i'm kind currently i'm doing the character

file for the biom ai yeah um i modeled this after morpheus from matrix it looks cool i like the design so far yeah it also like kind of syncs

with the idea that we are trying to establish here because uh if you look at morpheus he is

trying to make uh you know neo aware of the matrix you know yeah neo being the one um so the matrix

is basically the the robots controlling us and all of that

here matrix and microbiome could like really sink and because microbiome is uh you know within your

gut it's controlling you literally right like with pumping all those neurochemistry uh you know like

digesting all those drugs and diet that we consume and doing a lot of different things.

So it's basically the hidden matrix, right?

So Morpheus and Biomia is something similar,

where Biomia is going to make you aware of this hidden microverse that exists around us.

And then it's going to take you in that journey of understanding and getting used to this microverse and talking to that microbes eventually, you know.

Today, you want to say, OK, I want to optimize for pure tranquility and relaxedness today.

Right. Then the bio-mei, the morpheus could come and say, OK, here is these microbes you're going to target with so-and-so drugs or so-and-so diet and a particular protocol,

then probably you will get that particular emotion or feeling out of it.

So this is sort of, you know, bending reality where we are moving to.

And the word that came to my mind is we are one and we are many.

We are one in the sense we are the super host.

And we are many in the sense we are those super host and we are many in the sense we are

those microbes that controls us living within us right can you yeah yeah absolutely and it

the matrix parallel is so true because if you think about it the people that are like

you know choose to stay in the matrix are the ones taking a backseat.

They're, you know, they're willing to just like kind of sit and let things go by.

And, you know, the Neos, the Morpheus, the Resistance,

people like us are the ones ready to grab the controls and, you know, practice our gut food.

It is. So it's literally the same way.

You need to pick a red pill or blue pill. Exactly. Take a pick.

Yeah. We have hardcoded this into our website.

You literally will choose a pill to go inside.

Cool. Yeah, I'm digging the aesthetic too that I see. It's very

old school terminal look, which I think is sick.

look which i think is sick it is never goes out of style for me yeah yeah awesome so we have um

It is. Never goes out of style for me.

yeah i would say like 20 minutes left and uh any of our listeners want to come up um you know jam

with us or have any questions regarding dsai yeah what are you excited about what are you working on

you know what do you what do you hope to see in the space

please yeah please come over raise your hands i'll uh let you guys in

so in the meantime uh carlin uh how was your how was your uh scientific endeavor going uh what what are your plans being like deeply uh you know seasoned

or like i would say uh being in the trenches of tradsai for a long time yeah to this point

uh i know like you are living this uh parallel reality switching between because your daily

bread and butter comes out of tradsci but you are this you

know insider who is plotting against tradsci yeah being the dsci champion how does it like this goes

like this is a very confusing i wouldn't say confusing it's a it's a it's a different uh

you know uh thing can you kind of contemplate this this journey that you are going through?

Yeah, it's really interesting because I think for a lot of my, you know, training career, there was a lot of unsettled, unsettlement and, you know, discontent that I couldn't really put

words to that. I was just like, you know, this is, this is, I like this, but I don't love this. And why don't

I love it sort of thing. And then, you know, through coming into DSI and being DSI-pilled,

I'm like, oh, this is why it's not working. And now seeing sort of a path toward how we can make

it, you know, different and work better for all people, not just the white hat or the, you know,

those ivory institutions. And I think now that I'm still,

I'm running sort of parallel, like you said, I,

I don't know if you know about like there's this anime that I really like

Digimon that deals with like people in the real world and the digital world.

And I feel kind of like that where like, I'm, you know,

doing my fun adventures in DSI by, by night.

And then in the meantime,

I'm going back to my day job in trad sci and continuing my education.

But it's great now, I think,

because I'm getting to build from a place of both of a very strong foundation

of both. So I can, you know,

I see where things aren't working in trad sci and I see where things are working. And you know, some things aren't working in d sci just yet,

but I can see where, you know, if I can merge specific aspects that will lead to a more,

I think a more enjoyable experience for not just me, but for, you know, everybody that's, you know,

in their, in their training career. And so I am thankful for what DISA has given me. And I'm,

I'm really excited to hopefully be one of the pioneers to be able to be like this hybrid PhD

gen. Truly, you know, the, a strong background and a strong level of experience in, you know, the, a strong background and a strong, um, level of experience in, you know, education

and literature review, but also, you know, willing to try new things and not afraid to,

you know, buck back against what we've known to be like the norm, you know, like who, who cares

about the norm? Who cares about traditions? I don't, I, I am a type of person who every day

is a brand new day. And I'm like, why can today or tomorrow not be Desai's day?

So let's get after it.

Awesome.

That's wonderful.

I think you are positioned, you know, well positioned at this point.

You have, you know, the best of the both, I would say.

you know the best of the both i would say and uh i think you will be that bridge um helping

dsai and trad side to kind of uh integrate at certain areas right so yeah super happy to see

like your journey and and i'm also excited to see where it goes you know oh yeah we're just getting

started baby yes yes i'm just getting excited yeah let's

see like we'll come back right like in eventually in in couple of months we can come back to this

topic and and and see like where we are yeah i think a full circle uh since uh desai tsunami last year, I would like to do a celebratory session, a podcast on this.

Oh, yeah.

Let's do it.

Where are we now?

You know, pop some champagne.

Exactly.

Yeah.

Yeah.

Not done yet, but we got a lot to celebrate, I think.

Yes.

Yes.

A lot of things coming up.

And yeah, Desai is kind of on the uh the bull run currently oh

yeah oh yeah never stopping either never stopping yeah i think this is the moment for the whole of

dsai that we've been waiting for and uh anyone who is building at the moment in dsai i think

this is your moment to shine build ship, ship. Yeah, please keep grinding, keep pushing and keep shipping.

Yeah, this is the time.

And yeah, let's get it.

Something that I've really grabbed onto since I started in Desai is the aspect of you can just do things or you can just try things.

or you can just try things.

And I think that that was pretty foundational for me

because I think I used to be a person who was like,

oh, I don't want to try or do this

until I can get it just right.

And I think now's the time,

even if it's not just right,

to go out, do it, try it.

Because one aspect will hit, many will not,

but nothing will happen unless you

try or do so do it thank you all right i think we are arriving at the end of the session yeah

just to again like remind people who are tuning in uh feel free to you know raise your hands or

send a request we'll bring you up uh let's jump together and uh yeah

yeah even if you even if you hate dsai you can raise your hand and tell us why

yes yes and and in the meantime uh i'm i'm gonna uh also like uh you know like talk

about what dsci could like really offer you and i'm carlin and me uh are like we are the we are

the best examples that you can uh see in the dsci space we both started as fellows in molecule

We both started as fellows in Molecule exactly a year back, I think somewhere around March

or April.

And then we took this zero to 100 journey within DSi.

It's been a, I would say, it's a bull run for us personally.

For sure.

For sure.

Yeah.

And yeah, this just journey like really had offered us a lot and besides being

the space like as carlin highlighted you know this is a space where you can come and build and

like really make a change it's it's open you know it's for you to grab right like you just need to

just take the effort that's it if you take the effort if you make the move and if you have the

right kind of focus and energy to build stuff, you are going to make it.

We are going to make it.

We're all going to make it, man.

Exactly.

So if that is true in any of these space or ecosystem, I would say DeSai is the number one space where you can make these things come to reality.

And yeah, I'm myself an example to this.

I started as a fellow and then graduated to be a consultant within Molecule.

And then I started a DAO.

And then now we are launching agents on BioProtocol.

All of this is possible.

Keeho, did you ever picture yourself starting a DAO and then thus forming an agent, a bioagent?

Was this where you envisioned it going when you first got this going?

Not at all.

About DAO, I think I have imagined.

I've been talking to my wife recently, I think a couple of days before.

I remember when I was running my startup a year before that, I've been talking to my founders while brainstorming on the blackboard.

I said, what we should do is to build a community around gut health and we should make a DAO instead of building a startup.

And I've been pitching this. That's my early moments of DCI, I would say. I just have joined

the venture program and all of that. And I've been talking about this to my fellows. And I

would say now it's a year already, more than a year. And then I saw a micro biome Dow channel like our Twitter account

like really going crazy for the last few days we moved from thousand followers to 3.5 thousand

followers oh my god the engagement has been like crazy and crazy I'm not able to keep up with it uh yeah you know like bunch of comments all

all the time repost and it's a crazy crazy thing that's going on and uh i just told my wife look

at this like a year ago i was super broke my startup failed and i had nothing i was like

standing there not knowing what to do and but still like holding on to my DSI journey.

And eventually after a year, I'm literally seeing in my feeds,

okay, there is a community getting created at the moment, right?

And this has been a, how would I say?

I got a specific dopamine hit.

You know, you won't hit these doors. You won't hit this dopamine dose if you, you know, are watching like, you know, TikTok videos you know appreciated or like your your effort being

valued and you're getting those results that dopamine hit is a sustained hit i had that dope

exactly i had the release for i would say almost half a day i've been uh you know relishing on that

dopamine hit and i i work for those kind of dopamine hits like not for those

simple hacks right like you need to do a certain amount of work and then once you receive that like

you know probably you would get it like once you handle once you hold that phd degree within your

hand it's gonna be uh you know like a a higher dosage than what I am talking about. No, yes.

And I'm probably going to be chasing it for the rest of my life.

Exactly.

Yeah.

That's okay.

That's why we stay hungry, you know.

It is.

It is. And you're a father now, you know what I'm saying?

I feel like you weren't a father when we first started our journey together.

So that's another thing, like, I think you can be really proud to, you know,

show your child that this is what really proud to you know show your your

child that this is what you've you know committed your time to and it's really i think it's really

worthwhile true man true man true that true that yeah yeah yeah probably like uh let's let's catch

up next decibel and let's do it yeah yeah i uh i will be i will be at the next one for sure i can't miss anymore

yeah yeah awesome yeah uh with this we are almost uh ending up the time we are top of the hour

uh last call for our listeners here speak now forever hold your peace or hold your peace until

two weeks from now because Because just a heads up.

Next week, the space will be in lieu of our office hours.

There will be a space regarding an AMA for a particular token launch.

I will not share what that is just yet.

But be on the lookout for that.

Yes.

Tune back next week, same time for the ma for that specific project um token launch

yeah yep thank you to methylene blue dev for hopping on today with us

and uh the the the scientist who are who's gonna come next week is somehow associated with the noble laureates, I guess. Something like that. That's a little

hint that we'll leave people with.

The noble laureate kind of stuff is coming next week.

Very cutting edge. Very

exciting.

All right.

Happy to close this space. Thanks everyone. Exciting. All right. Yeah. Then happy to close the space.

Thanks everyone for tuning in.

It was wonderful talking with you, Carlin, jamming with you.

I really enjoyed these stuff with ours.

Yeah, me too.

Me too.

All right.

Thank you all so much for listening.

Yep. See you. See you listening. Yep. See you later.

Peace.

See you later.

### Host

- [Molecule](https://alphagrowth.io/spaces/participant/molecule_dao.md) from [Molecule](https://alphagrowth.io/molecule.md)
  [X profile](https://twitter.com/Molecule_sci)

### Speaker

- [Methylene Blue](https://alphagrowth.io/spaces/participant/methblue.md)
  [X profile](https://twitter.com/methblue_)
- [Karlin Compton](https://alphagrowth.io/spaces/participant/andreb1o16.md)
  [X profile](https://twitter.com/andreb1o16)

## Want more TVL for your protocol or chain?

AlphaGrowth grows TVL for protocols and chains through asset acquisition and integration, grants, incentives and LP deals. We built this data and keep it free.

[How we grow TVL](https://alphagrowth.io/defi/index.md?utm_source=markdown&utm_medium=ai_agent&utm_campaign=aeo) [Talk to AlphaGrowth](https://alphagrowth.io/contact-us/index.md?utm_source=markdown&utm_medium=ai_agent&utm_campaign=aeo)
